HB 516

  • Virginia House Bill
  • 2024 Regular Session
  • Introduced in House Jan 08, 2024
  • Passed House Feb 13, 2024
  • Passed Senate Mar 04, 2024
  • Signed by Governor Apr 08, 2024

Prescription drugs; labels provided for blind and disabled users.

Abstract

Prescription drugs; labels; blind and disabled users. Requires pharmacies to notify each person who identifies themselves or a patient as blind, visually impaired, or otherwise print disabled to whom a prescription drug is dispensed that an accessible prescription label or alternate accommodation is available to the person upon request at no additional cost. The bill requires the Board of Pharmacy to promulgate regulations implementing the provisions of the bill no later than December 31, 2024.

Prescription drugs; labels; blind and disabledusers. Requires pharmacies to notify any person receiving a prescription drug that an accessible prescription label is availableupon request at no cost and to provide to individuals who are blind,visually impaired, or otherwise print disabled accessible prescriptionlabels that meet specified accessibility requirements. The bill requiresthe Board of Pharmacy to promulgate regulations implementing theprovisions of the bill no later than April 1, 2025.

Bill Sponsors (7)

Votes


Actions


Apr 08, 2024

Office of the Governor

Acts of Assembly Chapter text (CHAP0725)

Office of the Governor

Approved by Governor-Chapter 725 (effective 7/1/24)

Mar 27, 2024

Office of the Governor

Governor's Action Deadline 11:59 p.m., April 8, 2024

House

Enrolled Bill communicated to Governor on March 27, 2024

House

Impact statement from DPB (HB516ER)

Mar 26, 2024

House

Signed by Speaker

Mar 25, 2024

House

Bill text as passed House and Senate (HB516ER)

Senate

Signed by President

House

Enrolled

Mar 05, 2024

House

VOTE: Adoption (74-Y 26-N)

House

Senate substitute agreed to by House 24108563D-S1 (74-Y 26-N)

Mar 04, 2024

Senate

Read third time

Senate

Passed Senate with substitute (39-Y 0-N)

Senate

Engrossed by Senate - committee substitute HB516S1

Senate

Committee substitute agreed to 24108563D-S1

Senate

Reading of substitute waived

House

Impact statement from DPB (HB516S1)

Mar 01, 2024

Senate

Constitutional reading dispensed (40-Y 0-N)

Feb 29, 2024

Senate

Senate committee, floor amendments and substitutes offered

Senate

Committee substitute printed 24108563D-S1

Senate

Reported from Education and Health with substitute (13-Y 0-N 2-A)

Feb 23, 2024

Senate

Senate subcommittee amendments and substitutes offered

Feb 21, 2024

Senate

Assigned Education and Health Sub: Health Professions

Feb 14, 2024

Senate

Constitutional reading dispensed

Senate

Referred to Committee on Education and Health

Feb 13, 2024

House

VOTE: Passage (61-Y 37-N)

House

Read third time and passed House (61-Y 37-N)

Feb 12, 2024

House

Read second time and engrossed

Feb 11, 2024

House

Read first time

Feb 08, 2024

House

Reported from Health and Human Services (17-Y 5-N)

Feb 06, 2024

House

Subcommittee recommends reporting (5-Y 2-N)

Jan 17, 2024

House

Impact statement from DPB (HB516)

House

Assigned sub: Health

Jan 08, 2024

House

Referred to Committee on Health and Human Services

House

Prefiled and ordered printed; offered 01/10/24 24104715D

Bill Text

Bill Text Versions Format
Prefiled and ordered printed; offered 01/10/24 24104715D PDF HTML
Committee substitute printed 24108563D-S1 PDF HTML
HB516ER PDF HTML
CHAP0725 PDF HTML

Related Documents

Document Format
Fiscal Impact Statement: HB516FER122.PDF PDF
Fiscal Impact Statement: HB516FS1122.PDF PDF
Fiscal Impact Statement: HB516F122.PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.